{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:48Z","timestamp":1761895188640,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":3378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.nrl.2010.07.018","type":"journal-article","created":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T04:35:32Z","timestamp":1286598932000},"page":"536-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Experiencia con la infusi\u00f3n continua de levodopa intraduodenal (Duodopa\u00ae) en pacientes con enfermedad de Parkinson avanzada en un hospital de segundo nivel asistencial"],"prefix":"10.1016","volume":"25","author":[{"given":"D.","family":"Santos-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"LLaneza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fuster-Sanjurjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Echarri-Piudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2010.07.018_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.1983.tb01513.x","article-title":"Problems associated with long-term levodopa treatment of Parkinson's disease","volume":"95","author":"Rinne","year":"1983","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.nrl.2010.07.018_bib0010","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/ana.21453","article-title":"How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?","volume":"64","author":"Fahn","year":"2008","journal-title":"Ann Neurol."},{"key":"10.1016\/j.nrl.2010.07.018_bib0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H","article-title":"Apomorphine: an underutilized therapy for Parkinson's disease","volume":"5","author":"Poewe","year":"2000","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0020","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa035275","article-title":"Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"349","author":"Krack","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nrl.2010.07.018_bib0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00315491","article-title":"Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease","volume":"45","author":"Bredberg","year":"1993","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.nrl.2010.07.018_bib0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNF.0b013e3180ed449f","article-title":"Enteral levodopa\/carbidopa infusion in advanced Parkinson disease: long-term exposure","volume":"31","author":"Nyholm","year":"2008","journal-title":"Clin Neuropharmacol."},{"key":"10.1016\/j.nrl.2010.07.018_bib0035","first-page":"21","article-title":"Infusi\u00f3n de Duodopa\u00ae en la enfermedad de Parkinson","volume":"7","author":"Ya\u00f1ez-Ba\u00f1a","year":"2007","journal-title":"Revista Espa\u00f1ola de Trastornos del Movimiento."},{"key":"10.1016\/j.nrl.2010.07.018_bib0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoenh","year":"1967","journal-title":"Neurology."},{"unstructured":"Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. En: Gillingham FJ, Donaldson ML, editors. Third Symposium on Parkinson's disease. Edinburgh: Livingston;1969.p.152\u20137.","key":"10.1016\/j.nrl.2010.07.018_bib0045"},{"key":"10.1016\/j.nrl.2010.07.018_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual Life Res."},{"unstructured":"Guy W, editor. ECDEU assessment manual for psychopharmacology. Rockville, MD. Alcohol, Drug Abuse, and Mental Health Administration, 1976 (DHEW publication no. ADM 76\u2013338).p.217\u201322","key":"10.1016\/j.nrl.2010.07.018_bib0055"},{"issue":"Pt 3","key":"10.1016\/j.nrl.2010.07.018_bib0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/brain\/awf050","article-title":"Clinical predictive factors of subthalamic stimulation in Parkinson's disease","volume":"125","author":"Welter","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.nrl.2010.07.018_bib0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1600-0404.2001.00153.x","article-title":"Duodenal levodopa infusion in Parkinson's disease--long-term experience","volume":"104","author":"Nilsson","year":"2001","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.nrl.2010.07.018_bib0070","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mds.21500","article-title":"Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome","volume":"22","author":"Antonini","year":"2007","journal-title":"Mov Disord."},{"unstructured":"Valldeoriola F. Continuous duodenal levodopa infusion \u2013 The Barcelona Experience. European Neurological Review Suppl.III International Forum on Advanced Parkinson's Disease. 2008; 3:25\u201328.","key":"10.1016\/j.nrl.2010.07.018_bib0075"},{"doi-asserted-by":"crossref","unstructured":"Devos D, for the French DUODOPA Study Group. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord. 2009; 24:993\u20131000.","key":"10.1016\/j.nrl.2010.07.018_bib0080","DOI":"10.1002\/mds.22450"},{"key":"10.1016\/j.nrl.2010.07.018_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.parkreldis.2009.07.015","article-title":"Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of life","volume":"16","author":"Puente","year":"2010","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.WNL.0000149637.70961.4C","article-title":"Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease","volume":"64","author":"Nyholm","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2010.07.018_bib0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mds.870130222","article-title":"Ten years\u2019 experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease","volume":"13","author":"Syed","year":"1998","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00002826-200305000-00010","article-title":"Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets","volume":"26","author":"Nyholm","year":"2003","journal-title":"Clin Neuropharmacol."},{"key":"10.1016\/j.nrl.2010.07.018_bib0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000113714","article-title":"Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease","volume":"5","author":"Antonini","year":"2008","journal-title":"Neurodegener Dis."},{"key":"10.1016\/j.nrl.2010.07.018_bib0115","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/mds.22596","article-title":"Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life","volume":"24","author":"Honig","year":"2009","journal-title":"Mov disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410270105","article-title":"Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease","volume":"27","author":"Mouradian","year":"1990","journal-title":"Ann Neurol."},{"issue":"13 Suppl.","key":"10.1016\/j.nrl.2010.07.018_bib0125","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.parkreldis.2007.06.002","article-title":"Continuous dopaminergic stimulation--from theory to clinical practice","author":"Antonini","year":"2007","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0130","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000183146.78892.3f","article-title":"Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements","volume":"65","author":"Nyholm","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2010.07.018_bib0135","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/mds.22708","article-title":"Suicide following duodenal levodopa infusion for Parkinson's disease","volume":"24","author":"Santos-Garc\u00eda","year":"2009","journal-title":"Mov Disord."},{"key":"10.1016\/j.nrl.2010.07.018_bib0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/ern.09.48","article-title":"Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management","volume":"9","author":"Antonini","year":"2009","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.nrl.2010.07.018_bib0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2009.10.021","article-title":"Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients","volume":"34","author":"S\u00e1nchez-Casta\u00f1eda","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485310001623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485310001623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:10:05Z","timestamp":1759324205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485310001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0213485310001623"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2010.07.018","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experiencia con la infusi\u00f3n continua de levodopa intraduodenal (Duodopa\u00ae) en pacientes con enfermedad de Parkinson avanzada en un hospital de segundo nivel asistencial","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2010.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}